Market Place
Sourcing Support
IGI`s Trispecific Antibody For Multiple Myeloma Published In Nature Cancer
11 Sep 2024 //
GLOBENEWSWIRE
Ichnos and Glenmark take a collaborative leap
30 Jan 2024 //
PR NEWSWIRE
Ichnos Sciences Data Selected For Presentation At The 65Th Ash Annual Meeting
09 Nov 2023 //
PR NEWSWIRE
Ichnos Sciences inks agreement with Astria Therapeutics for OX40
13 Oct 2023 //
INDIAN PHARMA POST
Astria pays Ichnos $15M to join eczema race led by Amgen, Sanofi
12 Oct 2023 //
FIERCE BIOTECH
Astria Announces Exclusive Worldwide License Agreement with Ichnos Sciences
11 Oct 2023 //
BUSINESSWIRE
Ichnos Sciences Receives Orphan Drug Designation For Antibody, ISB 2001
07 Jul 2023 //
PR NEWSWIRE
Ichnos Sciences Welcomes Lida Pacaud, M.D., As New Chief Medical Officer
26 Jun 2023 //
PR NEWSWIRE
Ichnos Sciences Receives Orphan Drug Designation For First-In-Class Bispecific
21 Mar 2023 //
PR NEWSWIRE
Glenmark`s biotech company Ichnos Sciences lays off 50
28 Feb 2023 //
ENDPTS
Ichnos doses first subject in Phase I/II trial of R/R MM treatment
29 Sep 2022 //
CLINICALTRIALSARENA
Ichnos Sciences Announces Initiation Of First-In-Human Study For Isb 1442
28 Sep 2022 //
PRNEWSWIRE
Ichnos Sciences Announces Selection Of Trispecific Antibody Isb 2001
09 May 2022 //
PRNEWSWIRE
Glenmark`s subsidiary Ichnos Sciences enters pact with Almirall for novel drug
13 Dec 2021 //
ECONOMIC TIMES
ICHNOS, ALMIRALL ENTER INTO LICENSING AGREEMENT FOR IL-1RAP ANTAGONIST MAb
13 Dec 2021 //
PRNEWSWIRE
ICHNOS PRESENTS PRECLINICAL DATA ON NOVEL ISB 1442 IN MULTIPLE MYELOMA
11 Dec 2021 //
PRNEWSWIRE
Intima snags Gilead`s former Yescarta leader for cell Tx chops
11 Nov 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.